Barry Ticho
Chief Medical Officer at Stoke Therapeutics, Inc. (STOK)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,05119,059 held (−5%) | $26.16 | $27K | -5.4% |
| Sep 3SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 3,94521,710 held (−15%) | $30.51 | $120K | -18.9% |
| Sep 3SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,60020,110 held (−7%) | $31.06 | $50K | -20.3% |
| Aug 18SEC | STOKStoke Therapeutics, Inc. | Sell | 4,52525,897 held (−15%) | $32.01 | $145K | -22.7% |
| Aug 18SEC | STOKStoke Therapeutics, Inc. | Sell | 24225,655 held (−1%) | $32.47 | $8K | -23.8% |
| Aug 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 5,90721,691 held (−21%) | $28.95 | $171K | -14.5% |
| Aug 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,26920,422 held (−6%) | $29.45 | $37K | -16.0% |
| Jul 6SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 6,72828,098 held (−19%) | $32.62 | $219K | -24.2% |
| Jul 6SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 50027,598 held (−2%) | $33.27 | $17K | -25.6% |
| Jun 3SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,79534,826 held (−5%) | $30.58 | $55K | -19.1% |
| May 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 2,24336,621 held (−6%) | $32.79 | $74K | -24.6% |
| Apr 3SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,83838,864 held (−5%) | $32.66 | $60K | -24.2% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 3,57750,071 held (−7%) | $32.74 | $117K | -24.4% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 2,58747,484 held (−5%) | $33.38 | $86K | -25.9% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 6,10041,384 held (−13%) | $31.28 | $191K | -20.9% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 48340,901 held (−1%) | $31.79 | $15K | -22.2% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 10340,798 held (−0%) | $32.85 | $3K | -24.7% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,46140,702 held (−3%) | $29.99 | $44K | -17.5% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,37323,783 held (−5%) | $30.76 | $42K | -19.6% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 32323,460 held (−1%) | $31.32 | $10K | -21.0% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,67321,787 held (−7%) | $31.33 | $52K | -21.0% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,98919,798 held (−9%) | $31.35 | $62K | -21.1% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 1,24417,932 held (−6%) | $29.56 | $37K | -16.3% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 76217,170 held (−4%) | $30.14 | $23K | -17.9% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 78916,381 held (−5%) | $30.34 | $24K | -18.5% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 1,22515,156 held (−7%) | $30.85 | $38K | -19.8% |
| Nov 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 3,7769,350 held (−29%) | $25.22 | $95K | -1.9% |
| Nov 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,4557,895 held (−16%) | $26.02 | $38K | -4.9% |
| Nov 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 6007,295 held (−8%) | $27.54 | $17K | -10.2% |
| Nov 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1007,195 held (−1%) | $29.35 | $3K | -15.7% |
| Oct 3SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 5,34313,126 held (−29%) | $23.64 | $126K | +4.7% |
- Sell
Chief Medical Officer Barry Ticho sold $27K of STOK at $26.16 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Barry Ticho sold $120K of STOK at $30.51 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Barry Ticho sold $50K of STOK at $31.06 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Barry Ticho sold $171K of STOK at $28.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Barry Ticho sold $37K of STOK at $29.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Barry Ticho sold $219K of STOK at $32.62 — pre-scheduled 10b5-1 plan sale.